Babcock & Wilcox Enterprises, Inc.
Business
Babcock & Wilcox Enterprises, Inc. provides renewable, environmental and thermal technologies and services for energy and emissions control applications. It offers hydrogen generation (BrightLoop™), oxygen‑fired biomass and waste‑to‑energy systems, emissions control technologies (including particulate, NOx, SO2 and mercury removal), steam generation equipment, aftermarket parts, construction, maintenance and field services. The company organizes its operations into three reporting segments: Babcock & Wilcox Renewable, Babcock & Wilcox Environmental, and Babcock & Wilcox Thermal. It serves global industrial, electric utility, municipal and waste‑to‑energy markets through direct contracts, competitive bids, joint ventures and regional manufacturing and service facilities in Europe, Canada, Mexico and other international markets.
Summary from filing dated 2025-03-31
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 588 | 581 | 587 | 609 | 711 | |
| Cost of operations | 444 | 454 | 466 | 464 | 536 | |
| Selling, general and administrative expenses | 119 | 125 | 135 | 153 | 152 | |
| Research and development costs | 2 | 5 | 7 | 4 | 2 | |
| Impairment of long-lived assets | 1 | 4 | 0 | — | — | |
| Loss (gain) on asset disposals, net | 1 | −400,000 | 100,000 | — | — | |
| Total costs and expenses | 567 | 587 | 608 | 611 | 691 | |
| Operating income (loss) | 21 | −6 | −20 | −1 | 19 | |
| Interest expense | −38 | −46 | −43 | −40 | — | |
| Interest income | 1 | 650,000 | 907,000 | 586,000 | 531,000 | |
| Gain (loss) on debt extinguishment | 2 | −7 | 0 | 0 | 7 | |
| Benefit plans, net | −10 | −31 | −38 | 38 | 48 | |
| Foreign exchange | 100,000 | 200,000 | −2 | −1 | — | |
| Other expense, net | −1 | −1 | −1 | −4 | −2 | |
| Total other expense | −45 | −85 | −84 | −4 | 8 | |
| Loss from continuing operations before income tax expense | −25 | −91 | −104 | −5 | 27 | |
| Income tax expense | 8 | 13 | 6 | 9 | −2 | |
| Loss from continuing operations | −33 | −104 | −109 | −14 | 29 | |
| (Loss) income from discontinued operations, net of tax | −3 | 44 | −88 | −12 | 2 | |
| Net loss attributable to stockholders | −36 | −60 | −197 | −23 | 31 | |
| Less: Dividends on Series A Preferred Stock | 15 | 15 | 15 | 15 | 9 | |
| Net loss attributable to stockholders of common stock, basic | −51 | −75 | −212 | −38 | 22 | |
| Net loss attributable to stockholders of common stock, diluted | −51 | −75 | −212 | −38 | 22 | |
| Continuing operations, basic (in dollars per share) | −0.45 | −1.3 | −1.39 | −0.29 | 0.23 | |
| Discontinued operations, basic (in dollars per share) | −0.03 | 0.48 | −0.99 | −0.14 | 0.03 | |
| Basic loss per share (in dollars per share) | −0.48 | −0.82 | −2.38 | −0.43 | 0.26 | |
| Diluted loss per share (in dollars per share) | −0.48 | −0.82 | −2.38 | −0.43 | 0.26 | |
| Basic (in shares) | 105 | 92 | 89 | 88 | 82 | |
| Diluted (in shares) | 105 | 92 | 89 | 88 | 84 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 89 | 23 | 40 | 76 | — | |
| Current restricted cash | 85 | 94 | 6 | — | — | |
| Accounts receivable trade, net of allowance for credit losses of $2.1 million and $1.3 million as of December 31, 2025 and December 31, 2024, respectively | 118 | 92 | 77 | 158 | 132 | |
| Contracts in progress | 73 | 79 | 46 | 118 | 80 | |
| Inventories, net | 61 | 58 | 98 | 103 | 80 | |
| Other current assets | 44 | 24 | 42 | 27 | 29 | |
| Current assets held for sale | 0 | 183 | 162 | 21 | 0 | |
| Total current assets | 471 | 553 | 498 | 558 | 582 | |
| Net property, plant and equipment, and finance leases | 66 | 61 | 69 | 85 | 86 | |
| Goodwill | 53 | 51 | 54 | 84 | 116 | |
| Intangible assets, net | 15 | 18 | 22 | 26 | 33 | |
| Right-of-use assets | 18 | 17 | 26 | 28 | 30 | |
| Long-term restricted cash | 27 | 10 | 297,000 | 21 | 0 | |
| Deferred tax assets | 945,000 | 167,000 | 2 | 2 | — | |
| Other assets | 13 | 16 | 21 | 27 | 55 | |
| Total assets | 663 | 727 | 776 | 942 | 913 | |
| Accounts payable | 69 | 88 | 83 | 131 | 86 | |
| Accrued employee benefits | 5 | 4 | 4 | 13 | 13 | |
| Advance billings on contracts | 112 | 56 | 52 | 131 | 68 | |
| Accrued warranty expense | 4 | 3 | 4 | 10 | 13 | |
| Financing lease liabilities | 2 | 2 | 1 | 1 | 2 | |
| Operating lease liabilities | 4 | 3 | 3 | 3 | 4 | |
| Other accrued liabilities | 40 | 28 | 51 | 54 | 54 | |
| Current borrowings | 67 | 125 | 6 | 4 | 12 | |
| Current liabilities held for sale | 0 | 98 | 138 | 25 | 0 | |
| Total current liabilities | 387 | 407 | 350 | 372 | 253 | |
| Borrowings, net of current portion | 19 | 9 | 35 | 13 | 2 | |
| Pension and other postretirement benefit liabilities | 176 | 193 | 173 | 136 | 183 | |
| Finance lease liabilities, net of current portion | 27 | 29 | 26 | 27 | 29 | |
| Operating lease liabilities, net of current portion | 15 | 14 | 24 | 26 | 27 | |
| Deferred tax liability | 11 | 10 | 10 | 12 | 1 | |
| Other noncurrent liabilities | 9 | 10 | 14 | 17 | 33 | |
| Total liabilities | 794 | 1,010 | 976 | 944 | 855 | |
| Preferred Stock, par value $0.01 per share, authorized shares of 20,000; issued and outstanding shares of 7,669 at both December 31, 2025 and 2024 | 77,000 | 77,000 | 77,000 | 77,000 | 77,000 | |
| Common stock, par value $0.01 per share, authorized shares of 500,000; issued and outstanding shares of 130,447 and 95,138 at December 31, 2025 and 2024, respectively | 6 | 5 | 5 | 5 | 5 | |
| Capital in excess of par value | 1,691 | 1,559 | 1,546 | 1,538 | 1,519 | |
| Treasury stock at cost, 2,690 and 2,379 shares at December 31, 2025 and 2024, respectively | −116 | −116 | −115 | −114 | −111 | |
| Accumulated deficit | −1,697 | −1,646 | −1,571 | −1,359 | −1,321 | |
| Accumulated other comprehensive loss | −16 | −87 | −66 | −73 | −59 | |
| Stockholders' deficit attributable to shareholders | −132 | −284 | −201 | −3 | 33 | |
| Non-controlling interest | 0 | 591,000 | 611,000 | 485,000 | 25 | |
| Total stockholders' deficit | −132 | −283 | −200 | −2 | 59 | |
| Total liabilities and stockholders' deficit | 663 | 727 | 776 | 942 | 913 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization of long-lived assets | 10 | 17 | 21 | 24 | 18 | |
| Impairment of long-lived assets | 10 | 10 | 57 | 7 | — | |
| Amortization of deferred financing costs and debt premium | 4 | 6 | 6 | 5 | 8 | |
| Amortization of guaranty fee | 108,000 | 3 | 935,000 | 856,000 | 2 | |
| Non-cash operating lease expense | 4 | 7 | 7 | 7 | 4 | |
| Gain on sale of business | −39 | −59 | 0 | 0 | — | |
| Loss on asset disposals | 6 | 431,000 | 200,000 | — | — | |
| Provision for (benefit from) deferred income taxes, including valuation allowances | 783,000 | 7 | −1 | 6 | −8 | |
| Mark to market, prior service cost amortization for pension and postretirement plans | 10 | 35 | 39 | −7 | −16 | |
| Stock-based compensation, net of associated income taxes | 3 | 5 | 9 | 10 | 8 | |
| Foreign exchange | −6 | 3 | 3 | 582,000 | — | |
| Bad debt (recovery) expense | −6 | −1 | 9 | — | — | |
| Accounts receivable trade, net | −16 | −12 | 13 | −28 | 225,000 | |
| Contracts in progress | −20 | 42 | −40 | −54 | −20 | |
| Other current and noncurrent assets | −14 | −6 | 10 | — | — | |
| Advance billings on contracts | 51 | −3 | −47 | 62 | 2 | |
| Inventories, net | −8 | −6 | −8 | −19 | −3 | |
| Income taxes | 168,000 | 10 | −6 | −248,000 | −2 | |
| Accounts payable | −58 | 8 | 13 | 53 | 7 | |
| Accrued and other current liabilities | 16 | −29 | −3 | −19 | −48 | |
| Accrued contract loss | −5 | −2 | 838,000 | 6 | −204,000 | |
| Pension liabilities, accrued postretirement benefits and employee benefits | −11 | −17 | −5 | −37 | −61 | |
| Other, net | −355,000 | 534,000 | −2 | −4 | −18 | |
| Net cash used in operating activities | −69 | −119 | −42 | −31 | −111 | |
| Purchase of property, plant and equipment | −17 | −11 | −10 | −13 | −7 | |
| Proceeds from sale of business and assets | 216 | 121 | 0 | 5 | 25 | |
| Purchases of securities | −6 | −7 | −6 | — | — | |
| Sales and maturities of securities | 4 | 7 | 8 | — | — | |
| Other, net | 0 | 34,000 | −102,000 | 466,000 | 0 | |
| Net cash provided by (used in) investing activities | 197 | 110 | −8 | −69 | −34 | |
| Borrowings on loan payable | 85 | 216 | 253 | 7 | 7 | |
| Repayments on loan payable | −139 | −122 | −227 | −17 | −846,000 | |
| Buyback of Senior Notes due 2026 | −111 | 0 | 0 | — | — | |
| Finance lease payments | −2 | −1 | −1 | −2 | −2 | |
| Payment of holdback funds from acquisition | 0 | −3 | −3 | 0 | 0 | |
| Payment of Preferred Stock dividends | −15 | −19 | −11 | −15 | −9 | |
| Shares of common stock returned to treasury stock | −386,000 | −336,000 | −1 | −3 | −5 | |
| Issuance of common stock, net | 130 | 8 | 0 | 0 | 161 | |
| Payment of non-controlling interest dividends | −118,000 | 0 | 0 | — | — | |
| Debt issuance costs | −7 | −8 | −658,000 | −1 | −25 | |
| Other, net | −260,000 | −179,000 | −153,000 | −48,000 | −222,000 | |
| Net cash (used in) provided by financing activities | −59 | 70 | 9 | −11 | 303 | |
| Effects of exchange rate changes on cash | 901,000 | −1 | −439,000 | −3 | 1 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 70 | 60 | −42 | −113 | 159 | |
| Income taxes paid, net | 9 | 8 | 7 | 8 | 5 | |
| Interest paid | 36 | 37 | 23 | 26 | 20 |